FLETCHER MARK

CIK 00012295291 companyTORONTO ONTARIO CANADA, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001229529

Recent Transactions

29 trades

Award
GENEREX BIOTECHNOLOGY CORP
Stock Option (right to buy)
2018-10-03+4,500→ 4,500 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock
2016-02-16$0.00/sh+4,447,111→ 15,821,836 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option
2016-02-16−4,447,111→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option
2016-02-09−5,143,787→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option
2016-02-09−1,457,195→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock
2016-02-09$0.00/sh+14,890,033→ 10,442,992 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option
2016-02-09+4,447,111→ 4,447,111 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option
2016-02-09−1,587,300→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (Right to Buy)
2014-10-06−470,726→ 0 total
Exercise/Conversion
GENEREX BIOTECHNOLOGY CORP
Common Stock
2014-10-06$0.00/sh+470,726→ 470,726 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2013-10-31+2,254,640→ 2,254,640 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (Right to Buy)
2013-06-06+1,587,300→ 1,587,300 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2013-04-01+5,143,787→ 5,143,787 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2012-06-19+1,457,195→ 1,457,195 total
Purchase
GENEREX BIOTECHNOLOGY CORP
Common Stock
2011-04-06$0.24/sh+20,000→ 286,077 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2011-03-25+1,500,000→ 1,500,000 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2010-03-08+300,000→ 300,000 total
Purchase
GENEREX BIOTECHNOLOGY CORP
Common Stock
2010-01-04$0.52/sh+8,700→ 266,077 total
Purchase
GENEREX BIOTECHNOLOGY CORP
Common Stock
2009-11-13$0.49/sh+10,000→ 257,377 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20+470,276→ 470,726 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20+250,000→ 250,000 total
Disposition to Issuer
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20−250,000→ 0 total
Disposition to Issuer
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Option (right to buy)
2009-10-20−470,726→ 0 total
Purchase
GENEREX BIOTECHNOLOGY CORP
Common Stock
2009-01-12$0.33/sh+2,200→ 247,377 total
Purchase
GENEREX BIOTECHNOLOGY CORP
Common Stock
2009-01-12$0.32/sh+10,159→ 245,177 total
Purchase
GENEREX BIOTECHNOLOGY CORP
Common Stock
2008-10-31$0.37/sh+500→ 210,518 total
Purchase
GENEREX BIOTECHNOLOGY CORP
Common Stock
2008-10-31$0.38/sh+24,500→ 235,018 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Options
2005-04-05+250,000→ 250,000 total
Award
GENEREX BIOTECHNOLOGY CORP
Common Stock Purchase Options
2005-04-05+470,726→ 470,726 total

Companies

GENEREX BIOTECHNOLOGY CORP
EVP & General Counsel

Recent Filings

Address

33 HARBOUR SQUARE SUITE 102

TORONTO ONTARIO CANADA, A1, M5J2G2

View on SEC.gov